Target intelligence / Profile preview

Testis-specific Y-encoded-like protein 5 (TSPYL5)

Target
TSPYL5
Molecular classification
Intrinsically disordered protein, Nucleosome assembly protein [NAP]-like domain containing, Chromatin-associated protein, Protein chaperone
01

Overview

Testis-specific Y-encoded-like protein 5 (TSPYL5) is a member of the TSPY-like protein family with a nucleosome assembly protein (NAP)-like domain, predominantly characterized as an intrinsically disordered protein[2]. TSPYL5 localizes to both nucleus (notably nucleolus) and cytoplasm, with localization governed by distinct sequence motifs. The protein functions as a chaperone for histones and ribosomal proteins, may participate in chromatin remodeling, and is implicated in regulating transcription, cell growth, and stress responses. Notably, TSPYL5 interacts with the tumor suppressor p53, modulating its ubiquitination, sumoylation, and cellular localization—thus potentially promoting oncogenic processes in cancers exhibiting cytoplasmic sequestration of p53[5]. TSPYL5 has emerging relevance as a marker and possible therapeutic target in oncology, though no current drugs directly target it[2][4][5].

Other names
TSPY like 5KIAA1750TSPY-like protein 5testis-specific Y-encoded-like protein 5
02

Mechanism of action

Not determined for drugs; mechanistically, TSPYL5 modulates cell growth, p53 function, and AKT pathway signaling, suggesting possible mechanisms for future therapeutics[4][5].

03

Biological functions

Chromatin remodelingHistone binding/chaperoningRegulation of p53/TP53 protein levelsRNA bindingRegulation of DNA-templated transcriptionCell growth regulationPositive regulation of phosphatidylinositol 3-kinase/protein kinase B (AKT) signal transductionRegulation of protein ubiquitinationInvolvement in cell response to gamma radiation
04

Disease associations

Cancer (notably in neuroblastoma, breast, liver, and colorectal cancers)Potential biomarker and therapeutic target in oncology
05

Safety considerations

none specifically described, but therapeutic targeting of TSPYL5 could impact chromatin structure and p53 signaling, predicting possible effects on genome stability and tumor suppression pathways
06

Biomarkers

TSPYL5 is suggested as a tumor marker in various cancers and for potential patient selection in oncology research[1][2].

Beyond the preview

Go deeper on Testis-specific Y-encoded-like protein 5 (TSPYL5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Testis-specific Y-encoded-like protein 5 (TSPYL5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call